Recombinant multi-species USP7 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine USP7 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene belongs to the peptidase C19 family, which includes ubiquitinyl hydrolases. This protein deubiquitinates target proteins such as p53 (a tumor suppressor protein) and WASH (essential for endosomal protein recycling), and regulates their activities by counteracting the opposing ubiquitin ligase activity of proteins such as HDM2 and TRIM27, involved in the respective process. Mutations in this gene have been implicated in a neurodevelopmental disorder. [provided by RefSeq, Mar 2016]
The Alternative Names of target: 2210010O09Rik,C16DELp13.2,DEL16P13.2,Deubiquitinating enzyme 7,HAFOUS,HAUSP,Hausp,Herpesvirus-associated ubiquitin-specific protease,TEF1,USP7,Ubiquitin carboxyl-terminal hydrolase 7,Ubiquitin thioesterase 7,Ubiquitin-specific-processing protease 7,Usp7

Target products collectionGo to USP7 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP12063-Ag-1/ GM-Tg-hg-IP12063-Ag-2 Human USP7 protein Human
GM-Tg-rg-IP12063-Ag-1/ GM-Tg-rg-IP12063-Ag-2 Rat USP7 protein Rat
GM-Tg-mg-IP12063-Ag-1/ GM-Tg-mg-IP12063-Ag-2 Mouse USP7 protein Mouse
GM-Tg-cynog-IP12063-Ag-1/ GM-Tg-cynog-IP12063-Ag-2 Cynomolgus/Rhesus macaque USP7 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP12063-Ag-1/ GM-Tg-felg-IP12063-Ag-2 Feline USP7 protein Feline
GM-Tg-cang-IP12063-Ag-1/ GM-Tg-cang-IP12063-Ag-2 Canine USP7 protein Canine
GM-Tg-bovg-IP12063-Ag-1/ GM-Tg-bovg-IP12063-Ag-2 Bovine USP7 protein Bovine
GM-Tg-equg-IP12063-Ag-1/ GM-Tg-equg-IP12063-Ag-2 Equine USP7 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP12063-Ag-1/ GM-Tg-hg-IP12063-Ag-2; GM-Tg-rg-IP12063-Ag-1/ GM-Tg-rg-IP12063-Ag-2;
GM-Tg-mg-IP12063-Ag-1/ GM-Tg-mg-IP12063-Ag-2; GM-Tg-cynog-IP12063-Ag-1/ GM-Tg-cynog-IP12063-Ag-2;
GM-Tg-felg-IP12063-Ag-1/ GM-Tg-felg-IP12063-Ag-2; GM-Tg-cang-IP12063-Ag-1/ GM-Tg-cang-IP12063-Ag-2;
GM-Tg-bovg-IP12063-Ag-1/ GM-Tg-bovg-IP12063-Ag-2; GM-Tg-equg-IP12063-Ag-1/ GM-Tg-equg-IP12063-Ag-2
Products Name USP7 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name USP7
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine USP7 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.